Cargando…
Role for Neoadjuvant Systemic Therapy for Potentially Resectable Pancreatic Cancer
SIMPLE SUMMARY: Pancreatic cancer is one of the deadliest cancers. It can only be cured by surgery, and most people with pancreatic cancer are diagnosed when the cancer is too far advanced to be able to be removed with an operation. Even when a patient can have surgery, in most instances, microscopi...
Autor principal: | Smaglo, Brandon G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136472/ https://www.ncbi.nlm.nih.gov/pubmed/37190305 http://dx.doi.org/10.3390/cancers15082377 |
Ejemplares similares
-
Profile and potential of ixabepilone in the treatment of pancreatic cancer
por: Smaglo, Brandon G, et al.
Publicado: (2014) -
Neoadjuvant therapy for resectable pancreatic cancer
por: Rahman, Sheikh Hasibur, et al.
Publicado: (2017) -
Neoadjuvant therapy for resectable pancreatic cancers
por: Inoue, Yosuke, et al.
Publicado: (2022) -
Neoadjuvant Treatment Strategies in Resectable Pancreatic Cancer
por: Lambert, Aurélien, et al.
Publicado: (2021) -
Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
por: Kim, Dong Uk
Publicado: (2022)